Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.W. Berenschot
Rituximab Sc and Iv Plus Chop Show Similar Efficacy and Safety in the Randomised Mabease Study in First-Line DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology
Safety Analysis of Australasian Leukaemia & Lymphoma Group Nhl29: A Phase Ii Study of Ibrutinib, Rituximab and Mini-Chop in Very Elderly Patients With Newly Diagnosed DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
Journal of Immunology Research
Medicine
Allergy
Immunology
Time and Motion Study for Rituximab Sc vs Iv in Colombian Patients With Non-Hodgkin Lymphoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Polarix: A Phase 3 Study of Polatuzumab Vedotin (Pola) Plus R-CHP Versus R-Chop in Patients (Pts) With Untreated DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
OP0142 Rituximab in Systemic Sclerosis : Safety and Efficacy Data From the Eustar Network
Safety and Efficacy of Venetoclax Combined With Rituximab, Ifosfamide, Carboplatin and Etoposide (Vicer) for Treatment of Relapsed Dlbcl: Final Results From the Phase 1trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Dose Finding Study to Assess Safety, Pk and Efficacy of Fimepinostat (Cudc-907) With Venetoclax or Rituximab Plus Bendamustine in Patients With Relapsed/Refractory Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
